Vanessa Patterson

Vanessa Patterson, PhD, MPH

Academic Information

Departments College of Pharmacy , Assistant Professor - Pharmacotherapy

Academic Office Information

vanessa.patterson@pharm.utah.edu

801-581-739

Research Interests

  • Pharmacoepidemiology
  • Health Economics and Outcomes Research (HEOR)
  • Real-World Data and Real-World Evidence (RWD/RWE)
  • Cardio-Oncology
  • Women’s Health

RESEARCH INTERESTS

Dr. Patterson’s research primarily focuses on health system evaluations using pragmatic research methods and real-world data. Her research interests are in pharmacoepidemiology, comparative effectiveness, and cost-effectiveness.  She works on drug utilization questions and optimization of health care delivery, with specific emphasis on cardiovascular care among cancer patients and survivors (Cardio-Oncology) and women’s health. 

AWARDS AND HONORS

  • 2008: Public Leadership Education Network (PLEN) - Women in Public Policy Fellow
  • 2022 – 2024: PhRMA Foundation - Health Outcomes Research Predoctoral Fellow
  • 2023: Harold C. Heim Award for Excellence in Research and Graduate Education

RELATED LINKS

FAR Webpage

College of Pharmacy

Education History

University of Colorado, Aurora, Colorado
Pharmaceutical Outcomes Research 		PhD
Graduate Training Tulane University, New Orleans, Louisiana
Epidemiology and Maternal and Child Health 		MPH
Tulane University, New Orleans, Louisiana
Environmental Health Sciences 		BSPH

Selected Publications

Journal Article

  1. Anderson HD, Patterson VP, Wright G, Rawlings JE, Moore GD, Leonard J, Page Ii RL. Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis. Ther Clin Risk Manag. 2023;19:745-753. doi: 10.2147/TCRM.S424961. eCollection 2023. PubMed PMID: 37744558; PubMed Central PMCID: PMC10516188.

  2. Tyner RJ, Whittington MD, Patterson VP, Ho M, Pincus S, Wiler JL, Michael SS. Differences in cardiac testing resource utilization using two different risk stratification schemes. Am J Emerg Med. 2023 Mar;65:179-184. doi: 10.1016/j.ajem.2022.12.023. Epub 2022 Dec 21. PubMed PMID: 36641961.

  3. Anderson HD, Patterson V, Wright G, Rawlings JE, Moore GD, Utter B, Taylor J, Leonard J, Page RL 2nd. Evaluation of an opioid pain teleconsultation service to address the opioid overdose epidemic in Colorado: A Health First Colorado demonstration project. J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):301-308. doi: 10.1016/j.japh.2022.11.009. Epub 2022 Nov 30. PubMed PMID: 36528493.

  4. Sieja A, Whittington MD, Patterson VP, Markley K, Holmstrom H, Rotholz S, Gonzalez C, Carpenter MS, Lin CT. The influence of a Sprint optimization and training intervention on time spent in the electronic health record (EHR). JAMIA Open. 2021 Jul;4(3):ooab073. doi: 10.1093/jamiaopen/ooab073. eCollection 2021 Jul. PubMed PMID: 34435176; PubMed Central PMCID: PMC8382277.

    More Selected Publications